scholarly article | Q13442814 |
P50 | author | Igor C Almeida | Q56772413 |
Alexandre F Marques | Q56867427 | ||
Alvaro José Romanha | Q107168961 | ||
P2093 | author name string | Rodrigo P Soares | |
Marcele N Rocha | |||
Sara L Santos | |||
Rafael R Assis | |||
Ana C Torrecilhas | |||
Felipe A Moura e Castro | |||
Gustavo F Freitas | |||
Silvane M Murta | |||
P2860 | cites work | The Genome Sequence of Trypanosoma cruzi, Etiologic Agent of Chagas Disease | Q22065799 |
Complement-mediated lysis of Trypanosoma cruzi trypomastigotes by human anti-alpha-galactosyl antibodies | Q28323738 | ||
Immunogenic Gal alpha 1----3Gal carbohydrate epitopes are present on pathogenic American Trypanosoma and Leishmania | Q28339616 | ||
Lytic anti-alpha-galactosyl antibodies from patients with chronic Chagas' disease recognize novel O-linked oligosaccharides on mucin-like glycosyl-phosphatidylinositol-anchored glycoproteins of Trypanosoma cruzi | Q28368291 | ||
Chagas disease | Q29615136 | ||
Structure of O-glycosidically linked oligosaccharides from glycoproteins of Trypanosoma cruzi CL-Brener strain: evidence for the presence of O-linked sialyl-oligosaccharides. | Q31958393 | ||
Proteomic analysis of Trypanosoma cruzi resistance to Benznidazole | Q33330702 | ||
Evolutionary considerations in relating oligosaccharide diversity to biological function | Q33687866 | ||
The structure, biosynthesis and functions of glycosylphosphatidylinositol anchors, and the contributions of trypanosome research. | Q33709881 | ||
Functional diversity in the trans-sialidase and mucin families in Trypanosoma cruzi | Q33945620 | ||
Secretory pathway of trypanosomatid parasites | Q33969495 | ||
Inositol metabolism in Trypanosoma cruzi: potential target for chemotherapy against Chagas' disease | Q34058066 | ||
Proinflammatory activity of glycosylphosphatidylinositol anchors derived from Trypanosoma cruzi: structural and functional analyses. | Q34394414 | ||
Nitric oxide is involved in control of Trypanosoma cruzi-induced parasitemia and directly kills the parasite in vitro | Q34546031 | ||
Cell signalling and Trypanosoma cruzi invasion | Q34994362 | ||
Specific chemotherapy of Chagas disease: controversies and advances | Q35569069 | ||
Improved proteomic approach for the discovery of potential vaccine targets in Trypanosoma cruzi | Q35660798 | ||
Role of the Toll/interleukin-1 receptor signaling pathway in host resistance and pathogenesis during infection with protozoan parasites. | Q35884180 | ||
The Trypanosoma cruzi-host-cell interplay: location, invasion, retention | Q36263007 | ||
Trypanosoma cruzi surface mucins: host-dependent coat diversity | Q36401388 | ||
Protozoan encounters with Toll-like receptor signalling pathways: implications for host parasitism. | Q36655907 | ||
Protein-glycan interactions in the control of innate and adaptive immune responses | Q37168156 | ||
Regulation of the expression of nitric oxide synthase and leishmanicidal activity by glycoconjugates of Leishmania lipophosphoglycan in murine macrophages | Q37306214 | ||
A new consensus for Trypanosoma cruzi intraspecific nomenclature: second revision meeting recommends TcI to TcVI. | Q37660962 | ||
Trans-sialidase and mucins of Trypanosoma cruzi: an important interplay for the parasite | Q37885531 | ||
Sensitivity of parasites to free radical damage by antiparasitic drugs | Q38141291 | ||
Mucin-like molecules form a negatively charged coat that protects Trypanosoma cruzi trypomastigotes from killing by human anti-alpha-galactosyl antibodies | Q38314745 | ||
DNA markers define two major phylogenetic lineages of Trypanosoma cruzi. | Q38559440 | ||
Leishmania infantum: Lipophosphoglycan intraspecific variation and interaction with vertebrate and invertebrate hosts | Q38949665 | ||
Leishmania tropica: intraspecific polymorphisms in lipophosphoglycan correlate with transmission by different Phlebotomus species | Q39474956 | ||
Elimination of Chagas disease transmission: perspectives | Q39945109 | ||
Highly purified glycosylphosphatidylinositols from Trypanosoma cruzi are potent proinflammatory agents | Q40410786 | ||
Structural and functional properties of Trypanosoma trans-sialidase | Q40572972 | ||
Activation of Toll-like receptor-2 by glycosylphosphatidylinositol anchors from a protozoan parasite | Q40797228 | ||
Trans-sialidase: a unique enzyme activity discovered in the protozoan Trypanosoma cruzi | Q40862448 | ||
Glycoconjugates isolated from Trypanosoma cruzi but not from Leishmania species membranes trigger nitric oxide synthesis as well as microbicidal activity in IFN-gamma-primed macrophages | Q41049635 | ||
Glycosylphosphatidylinositol-anchored mucin-like glycoproteins isolated from Trypanosoma cruzi trypomastigotes initiate the synthesis of proinflammatory cytokines by macrophages. | Q41104715 | ||
O-glycosidically linked N-acetylglucosamine-bound oligosaccharides from glycoproteins of Trypanosoma cruzi | Q41859000 | ||
A unique natural human IgG antibody with anti-alpha-galactosyl specificity | Q41878407 | ||
Hexose uptake in Trypanosoma cruzi: structure-activity relationship between substrate and transporter. | Q41978261 | ||
Adhesion and interiorization of Trypanosoma cruzi in mammalian cells | Q42825388 | ||
Alpha-N-acetylglucosamine-linked O-glycans of sialoglycoproteins (Tc-mucins) from Trypanosoma cruzi Colombiana strain. | Q43276759 | ||
Drug resistance in Trypanosoma cruzi is not associated with amplification or overexpression of P-glycoprotein (PGP) genes | Q43770191 | ||
Inhibition of a p38/stress-activated protein kinase-2-dependent phosphatase restores function of IL-1 receptor-associate kinase-1 and reverses Toll-like receptor 2- and 4-dependent tolerance of macrophages | Q44521272 | ||
Susceptibility and natural resistance of Trypanosoma cruzi strains to drugs used clinically in Chagas disease | Q46193271 | ||
Molecular characterization of cytosolic and mitochondrial tryparedoxin peroxidase in Trypanosoma cruzi populations susceptible and resistant to benznidazole | Q46238977 | ||
Deletion of copies of the gene encoding old yellow enzyme (TcOYE), a NAD(P)H flavin oxidoreductase, associates with in vitro-induced benznidazole resistance in Trypanosoma cruzi. | Q46916018 | ||
The Lipid Structure of the Glycosylphosphatidylinositol-anchored Mucin-like Sialic Acid Acceptors of Trypanosoma cruzi Changes during Parasite Differentiation from Epimastigotes to Infective Metacyclic Trypomastigote Forms | Q47630684 | ||
Evaluation of 4 polymerase chain reaction protocols for cultured Leishmania spp. typing | Q48657496 | ||
A highly sensitive and specific chemiluminescent enzyme-linked immunosorbent assay for diagnosis of active Trypanosoma cruzi infection. | Q52558374 | ||
Functional identification of galactosyltransferases (SCGs) required for species-specific modifications of the lipophosphoglycan adhesin controlling Leishmania major-sand fly interactions. | Q52603674 | ||
Impaired production of proinflammatory cytokines and host resistance to acute infection with Trypanosoma cruzi in mice lacking functional myeloid differentiation factor 88. | Q53905520 | ||
In vivo selection of a population of Trypanosoma cruzi and clones resistant to benznidazole. | Q54144383 | ||
Reconstitution of GDP-mannose transport activity with purified Leishmania LPG2 protein in liposomes. | Q54397725 | ||
Detection of mycoplasma contaminations. | Q54702212 | ||
Trypanosoma cruzi: parasite shed vesicles increase heart parasitism and generate an intense inflammatory response | Q57067411 | ||
Glycoconjugates of Trypanosoma cruzi: a 74 kD antigen of trypomastigotes specifically reacts with lytic anti-alpha-galactosyl antibodies from patients with chronic Chagas disease | Q58844407 | ||
Direct lysis of Trypanosoma cruzi: a novel effector mechanism of protection mediated by human anti-gal antibodies | Q58844845 | ||
Real time PCR strategy for the identification of major lineages of Trypanosoma cruzi directly in chronically infected human tissues | Q58845592 | ||
The surface coat of the mammal-dwelling infective trypomastigote stage of Trypanosoma cruzi is formed by highly diverse immunogenic mucins | Q58845802 | ||
In-vivo treatment with benznidazole enhances phagocytosis, parasite destruction and cytokine release by macrophages during infection with a drug-susceptible but not with a derived drug-resistant Trypansoma cruzi population | Q58847063 | ||
GROWTH AND DIFFERENTIATION IN TRYPANOSOMA CRUZI. I. ORIGIN OF METACYCLIC TRYPANOSOMES IN LIQUID MEDIA | Q58861039 | ||
Requirement of Mitogen-Activated Protein Kinases and I B Phosphorylation for Induction of Proinflammatory Cytokines Synthesis by Macrophages Indicates Functional Similarity of Receptors Triggered by Glycosylphosphatidylinositol Anchors from Parasitic | Q58867207 | ||
Characterization of D-glucose transport in Trypanosoma rangeli | Q58869348 | ||
Structural variation in the glycoinositolphospholipids of different strains of Trypanosoma cruzi | Q71939521 | ||
Structural characterization of the major glycosylphosphatidylinositol membrane-anchored glycoprotein from epimastigote forms of Trypanosoma cruzi Y-strain | Q72132126 | ||
Trypanosoma cruzi: characterisation of the gene encoding tyrosine aminotransferase in benznidazole-resistant and susceptible populations | Q80747461 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Trypanosoma cruzi | Q150162 |
P304 | page(s) | 87-96 | |
P577 | publication date | 2012-07-01 | |
P1433 | published in | American Journal of Tropical Medicine and Hygiene | Q15766943 |
P1476 | title | Intraspecies variation in Trypanosoma cruzi GPI-mucins: biological activities and differential expression of α-galactosyl residues | |
P478 | volume | 87 |
Q41552272 | Depletion of regulatory T cells decreases cardiac parasitosis and inflammation in experimental Chagas disease |
Q28487915 | Differential distribution of genes encoding the virulence factor trans-sialidase along Trypanosoma cruzi Discrete typing units |
Q33698046 | Enhancing glycan isomer separations with metal ions and positive and negative polarity ion mobility spectrometry-mass spectrometry analyses |
Q26783960 | Extracellular Vesicles: Role in Inflammatory Responses and Potential Uses in Vaccination in Cancer and Infectious Diseases |
Q92081125 | Extracellular vesicles isolated from Trypanosoma cruzi affect early parasite migration in the gut of Rhodnius prolixus but not in Triatoma infestans |
Q40086382 | Mast Cell Coupling to the Kallikrein-Kinin System Fuels Intracardiac Parasitism and Worsens Heart Pathology in Experimental Chagas Disease. |
Q56778835 | Potential use of synthetic α-galactosyl-containing glycotopes of the parasite Trypanosoma cruzi as diagnostic antigens for Chagas disease |
Q55154050 | Proteomic analysis reveals different composition of extracellular vesicles released by two Trypanosoma cruzi strains associated with their distinct interaction with host cells. |
Q48099205 | Specific activation of CD4- CD8- double-negative T cells by Trypanosoma cruzi-derived glycolipids induces a proinflammatory profile associated with cardiomyopathy in Chagas patients. |
Q36779501 | Structure of a complex phosphoglycan epitope from gp72 of Trypanosoma cruzi. |
Q36353119 | Synthesis of Galα(1,3)Galβ(1,4)GlcNAcα-, Galβ(1,4)GlcNAcα- and GlcNAc-containing neoglycoproteins and their immunological evaluation in the context of Chagas disease. |
Q61798673 | Theft and Reception of Host Cell's Sialic Acid: Dynamics of Trypanosoma Cruzi Trans-sialidases and Mucin-Like Molecules on Chagas' Disease Immunomodulation |
Q36710445 | Two biochemically distinct lipophosphoglycans from Leishmania braziliensis and Leishmania infantum trigger different innate immune responses in murine macrophages |
Q36326969 | Vesicles from different Trypanosoma cruzi strains trigger differential innate and chronic immune responses |
Search more.